Drugs / In-111 DTPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00477503 Comparator | May 2007 → Jul 2009 | brain neoplasm | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | In-111 DTPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00477503 ↗ |
| Known as | In-111 pentetate | “In-111 DTPA (In-111 pentetate)” NCT00477503 ↗ |
| Modality | Diagnostic / imaging agent | “In-111 DTPA is a radioactive dye that is standardly used to check the flow of CSF.” NCT00477503 ↗ |